en
/
sv
About Elicera
Elicera in brief
Board
Team
Advisors
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
CAR T-cell therapy
Challenges
Mode-of-action
Scientific publications
Pipeline
Pipeline
ELC-100
ELC-201
ELC-301
ELC-401
Clinical trials
Patent portfolio
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
IPO
Analyst Coverage
News
News
Press Releases
Events
Contact
en
/
sv
General Meeting
Elicera's Annual General Meeting will be held on March 7th, 2022
Annual General Meeting - May 16th, 2023
Fullmaktsformulär (Swe)
pdf
Call for AGM 2023 (Swe)
pdf
Styrelsens fullständiga förslag till emissionsbemyndigande (Swe)
pdf
Kommuniké årsstämma 2023
pdf
Minutes AGM 2023 (Swe)
pdf
Annual General Meeting - March 7th, 2022
Call for AGM 2022
pdf
Styrelsens fullständiga förslag till emissionsbemyndigande
pdf
Fullmaktsformulär årssstämma 220307
pdf
Minutes - AGM 2022
pdf
Communiqué (Swe) AGM 2022
pdf
Annual General Meeting - April 26th, 2021
Form for mail-in-ballot (AGM 2021, in Swedish)
pdf
Notice to attend (AGM 2021, in Swedish)
pdf
Power of Attorney (AGM 2021, in Swedish)
pdf
Communique AGM 2021
pdf
Extra General Meeting - March 18th, 2021
Form for mail-in-ballot (in Swedish)
pdf
Notice to attend (in Swedish)
pdf
Power of Attorney (in Swedish)
pdf
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our
Integrity policy
.
Deny
Accept